STOCK TITAN

UNITEDHEALTH GROUP (UNH) SEC Filings, Jun-Jul 2026

UNH NYSE
Rhea-AI Summary

FLYNN TIMOTHY PATRICK reported acquisition or exercise transactions in this Form 4 filing.

UNITEDHEALTH GROUP INC director Timothy Patrick Flynn received an equity award of 225 shares of common stock-equivalent units as compensation. These deferred stock units were granted at a price of $0.00 per unit, are immediately vested, and must be held until he completes his Board service.

After this grant, Flynn directly holds 10,875 shares of UnitedHealth Group common stock. Separately, a trust associated with him indirectly holds 6,033 shares. The filing does not show any open‑market buying or selling; this is a routine compensation-related award rather than a discretionary trade.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.

UNITEDHEALTH GROUP INC director Charles D. Baker received an equity award of 220 deferred stock units as regular quarterly compensation for board service. These units are immediately vested but must be held until he completes his service on the Board. Following this grant, he directly holds 2,396 common shares-equivalent.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UNITEDHEALTH GROUP INC executive Erin McSweeney, EVP & Chief People Officer, acquired 48.23 shares of common stock on June 23, 2026 as a grant of dividend equivalents on outstanding restricted stock units, at a stated price of $0.00 per share. After this compensation-related award, her direct holdings increased to 15,601.153 shares of common stock. The dividend-equivalent shares are subject to the same vesting conditions as the underlying restricted stock units and are forfeited if those units do not vest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.

UnitedHealth Group director John H. Noseworthy received 41 shares of Common Stock as a grant tied to dividend equivalents on vested deferred stock units. These additional shares were issued at no cost and bring his directly held position to 7,410 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

GARCIA PAUL R reported acquisition or exercise transactions in this Form 4 filing.

UNITEDHEALTH GROUP INC director Paul R. Garcia reported a small equity-related compensation change. He received 13 shares of common stock on June 23, 2026 as a grant or award tied to dividend equivalents on vested deferred stock units, bringing his direct holdings to 3,686 shares of common stock.

In addition, he reported indirect holdings of 55 shares held by Trust 3, 45 shares held by Trust 2, and 2,146 shares held by a revocable trust. The new 13-share award is immediately vested and follows the same terms as the underlying deferred stock units, indicating a routine, compensation-related adjustment rather than an open‑market trade.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

MONTGOMERY RICE VALERIE MD reported acquisition or exercise transactions in this Form 4 filing.

UNITEDHEALTH GROUP INC director receives additional stock-linked units through dividends. Director Valerie Montgomery Rice was granted 41 shares of Common Stock on June 23, 2026 at a stated price of $0.00 per share. These represent dividend equivalents paid on vested deferred stock units and are immediately vested under the same terms as the underlying units. Following this compensation-related award, she directly holds 7,656 shares of UnitedHealth Group common stock, indicating a routine, small-scale adjustment to her equity-based holdings rather than an open-market transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UNITEDHEALTH GROUP INC director Kristen Gil reported a small equity-related update tied to existing awards. On June 23, 2026, Gil acquired 8 shares of Common Stock as a grant or award, recorded at $0.00 per share. A footnote explains these represent dividend equivalents paid on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. After this acquisition, Gil directly holds 2,411 shares of UnitedHealth Group common stock and also has an indirect holding of 3,800 shares held by a trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UNITEDHEALTH GROUP INC director Scott Gottlieb reported a small share award. On the reported date, he acquired 3 shares of common stock at no cost as a grant of dividend equivalents on vested deferred stock units, bringing his direct holdings to 449 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

UNITEDHEALTH GROUP INC executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported an automatic share-based compensation adjustment. He acquired 82.488 shares of common stock at a stated price of $0.00 per share as a grant or award.

According to the footnote, these shares represent dividend equivalents paid on outstanding restricted stock units and are subject to the same vesting conditions as those units, meaning they can be forfeited if vesting is not achieved. Following this grant, Conway directly holds 16,996.797 shares of UnitedHealth common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

UNITEDHEALTH GROUP INC executive Noel Timothy John, Chief Executive Officer of UnitedHealthcare (UHC), reported an acquisition of 76.063 shares of common stock. These represent dividend equivalents paid on outstanding restricted stock units and carry the same vesting conditions as the underlying units. After this award, his directly held common stock position reported in this filing is 17,650.716 shares. The transaction reflects compensation-related accruals rather than an open‑market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many UNITEDHEALTH GROUP (UNH) SEC filings are available on StockTitan?

StockTitan tracks 208 SEC filings for UNITEDHEALTH GROUP (UNH), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for UNITEDHEALTH GROUP (UNH)?

The most recent SEC filing for UNITEDHEALTH GROUP (UNH) was filed on July 6, 2026.